Načítá se...
Inhibitory receptor agonists: The future of autoimmune disease therapeutics?
Central and peripheral tolerance both contribute to protection against autoimmunity. The pathogenesis of autoimmunity, however, can result from critical deficits or limitations in peripheral and/or central tolerance mechanisms, presenting an opportunity for therapeutic intervention. Recent advances...
Uloženo v:
| Vydáno v: | Curr Opin Immunol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7744338/ https://ncbi.nlm.nih.gov/pubmed/32619929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2020.06.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|